National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2017 (No. 6) (PB 65 of 2017) (Cth)

PB 65 of 2017

National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2017 (No. 6)

National Health Act 1953

I, PENNY SHAKESPEARE, First Assistant Secretary, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated 28 August 2017

PENNY SHAKESPEARE

First Assistant Secretary

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

Amendment instrument – Pharmaceutical benefits – early supply

1          Name of Instrument

(1)      This Instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2017 (No. 6)

(2)This Instrument may also be cited as PB 65 of 2017.

2          Commencement

This Instrument commences on 1 September 2017.

3          Amendment of PB 120 of 2015

Schedule 1 amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015).

Schedule 1        Amendments

1. Schedule 1, after entry for Ibandronic acid

insert:

Idelalisib	Tablet 100 mg	20	60	5
Idelalisib	Tablet 150 mg	20	60	5

1. Schedule 1, after entry for Ustekinumab

insert:

Ustekinumab Injection 45 mg in 0.5 mL 20 2 0